ASDERA LLC has a total of 14 patent applications. It increased the IP activity by 233.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are TECHNOLOGY DEV COMPANY LTD, LIPID THERAPEUTICS GMBH and PABORJI MEHDI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Wittkowski Knut M | 10 |
#2 | Wittkowski Knut | 3 |
Publication | Filing date | Title |
---|---|---|
CA3076821A1 | Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation | |
US2020268788A1 | Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation | |
WO2017163128A2 | Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders |